News
It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...
Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...
The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to ...
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
Moderna has announced that it plans to cut down 10% of its workforce by the end of the year. CEO Stephane Bancel said in a ...
Q2 2025 Earnings Call Transcript August 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.13, ...
Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the ...
CAMBRIDGE, Mass. — Massachusetts-based Moderna announced Thursday that it plans to slash the size of its global workforce by ...
In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...
Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of ...
AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...
Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the end of the year as part of its effort to cut costs. In a statement on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results